Search

Novocure Ltd

Fermé

SecteurSoins de santé

13.13 0.15

Résumé

Variation du prix de l'action

24h

Actuel

Min

12.49

Max

13.25

Chiffres clés

By Trading Economics

Revenu

55M

-16M

Ventes

9.5M

184M

BPA

-0.13

Marge bénéficiaire

-8.529

Employés

1,605

EBITDA

57M

-6.3M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+62.73% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-169M

1.7B

Ouverture précédente

12.98

Clôture précédente

13.13

Novocure Ltd Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

29 oct. 2026, 23:46 UTC

NovoCure Limited is trading modestly higher in after-market hours, showing a stronger move compared to recent trends of lower finishes over the last three sessions.

28 oct. 2026, 23:36 UTC

NovoCure Limited's shares rose in after-market trading, recovering from an earlier low to achieve a higher level later in the session.

27 oct. 2026, 20:01 UTC

NovoCure Limited is trading higher, having reached a notable peak earlier in the session.

26 oct. 2026, 20:06 UTC

Novocure Ltd shares fell sharply, marking five consecutive sessions of declines and closing lower from Friday's close, remaining below the 20-day moving average.

23 oct. 2026, 20:07 UTC

Novocure Ltd shares fell, reflecting the broader market's decline, amid economic indicators showing a slight drop in the S&P Global Composite PMI and rising oil prices.

22 oct. 2026, 20:07 UTC

Novocure Ltd shares are declining, continuing a downward trend since Wednesday, despite an early uptick; the stock hit its lowest point in the early afternoon.

20 oct. 2026, 20:08 UTC

Novocure Ltd shares advanced sharply amid a broader market rally in the health care equipment sector, pulling back slightly from a mid-session peak.

19 oct. 2026, 20:01 UTC

Novocure Ltd shares are sharply higher, reaching a peak gain of over six percent.

16 oct. 2026, 19:16 UTC

Novocure Ltd shares fell sharply, trading significantly below its 20-day moving average and near the lower end of its one-month range.

15 oct. 2026, 19:46 UTC

Novocure Ltd shares are advancing, reaching a peak cumulative return during Thursday's trading session.

14 oct. 2026, 20:13 UTC

Novocure Ltd's shares advanced modestly during after-market hours on Wednesday, reflecting a cumulative return of 0.58% since the market closed.

9 oct. 2026, 19:45 UTC

Novocure Ltd is trading higher.

8 oct. 2026, 20:06 UTC

Novocure Ltd shares fell sharply, continuing a downward trend with a notable decline since Wednesday's close, reaching their lowest point around midday.

7 oct. 2026, 20:07 UTC

Novocure Ltd shares fell sharply, continuing a decline since Tuesday's close and now trading near the bottom of their one-month range.

6 oct. 2026, 20:06 UTC

Novocure Ltd's shares declined sharply, settling near the lower end of their one-month range and below the 20-day moving average amid overall market weakness.

5 oct. 2026, 20:06 UTC

Novocure Ltd's shares advanced, recovering from an earlier dip and reaching a peak, though they remain near the lower end of their one-month trading range.

2 oct. 2026, 20:00 UTC

Novocure Ltd shares fell sharply, breaking a trend of higher daily closes and contrasting with prior upward momentum.

1 oct. 2026, 20:13 UTC

Novocure Ltd is trading higher in after-market hours, holding steady near the lower end of its one-month trading range following Thursday's close.

24 sept. 2026, 20:07 UTC

Novocure Ltd's shares fell sharply, continuing a decline since Wednesday's close, amid broader market weakness and routine fluctuations throughout the session.

21 sept. 2026, 19:16 UTC

Novocure Ltd shares fell sharply, trading below their 20-day moving average and around the midpoint of their one-month trading range.

18 sept. 2026, 23:36 UTC

Novocure Ltd is trading modestly higher in after-market hours, recovering from a decline earlier in the day but remaining below its 20-day moving average.

17 sept. 2026, 19:51 UTC

Novocure Ltd is trading higher amid a broader market rally, boosted by strong labor market data and a positive Philadelphia Fed Manufacturing Index.

16 sept. 2026, 23:06 UTC

Novocure Ltd has gained modestly in after-market trading, recovering from earlier lows but remains below its 20-day moving average.

15 sept. 2026, 19:26 UTC

Novocure Ltd. shares are advancing, rebounding from an earlier low, after three consecutive sessions of gains. The stock remains below its 20-day moving average.

14 sept. 2026, 20:21 UTC

Novocure Ltd shares are higher in after-market hours, continuing a trend of daily gains. No specific news was identified to explain the movement.

11 sept. 2026, 19:36 UTC

Novocure shares are trading higher, buoyed by positive sentiment in the health care equipment sector and broader market dynamics despite some volatility earlier in the session.

10 sept. 2026, 19:46 UTC

Novocure Ltd. shares are lower, continuing a three-session decline amid broader market pressure from the European Central Bank's interest rate hike and inflation warnings.

9 sept. 2026, 23:06 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a three-session decline and remaining below their 20-day moving average. No specific news was identified.

8 sept. 2026, 22:26 UTC

Shares of Novocure Ltd. are higher in after-market trading, fluctuating within a narrow range since Tuesday's close and remaining near the lower end of their one-month range.

2 sept. 2026, 20:08 UTC

News

Novocure Ltd is trading higher as it prepares for two investor events, including chats at the Wells Fargo and Morgan Stanley healthcare conferences.

Comparaison

Variation de prix

Novocure Ltd prévision

Objectif de Prix

By TipRanks

62.73% hausse

Prévisions sur 12 Mois

Moyen 21.333 USD  62.73%

Haut 29 USD

Bas 15 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

2

Achat

1

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
help-icon Live chat